- This event has passed.
Presentation by Dr. Paolo Parini from the Karolinska Institutet
11/13/2015 @ 10:00 am - 11:00 am
Join us on November 13 at 10 am at Biotech Place, 155 A&B, for the Molecular Medicine Research Seminar, featuring Paolo Parini, MD.
Title: ACAT2 depletion reduces steatosis (NAFLD) and improves insulin sensitivity in mice
About Dr. Parini: Dr. Paolo Parini obtained his M.D. degree in his home country of Italy in the city of Bologna. After starting specialty training in Gastroenterology in Bologna, he left Italy and moved to Sweden where he entered a PhD program in Molecular Nutrition in the Metabolism Unit of the Department of Medicine at the Karolinska Institutet in Stockholm under the guidance of Professors Bo Angelin and Mats Rudling. For the PhD, he studied the hormonal regulation of hepatic cholesterol and lipoprotein metabolism including studies of estrogen and growth hormone. After postdoctoral training in Stockholm and in Winston-Salem at Wake Forest University School of Medicine, he accepted a position at the Karolinska as an Assistant Professor of Clinical Chemistry. He was promoted to Associate Professor in 2007 and to full Professor in 2012. He is currently a Professor and Head of the Clinical Chemistry Unit in the Department of Laboratory Medicine at the Karolinska Institutet. He holds many titles in research organizations including Chief Organizer of the Annual Meeting of the Scandinavian Society for Atherosclerosis Research and is the current Chairman of the Scandinavian Society for Atherosclerosis Research. He participates on many government scientific advisory boards on behalf of the Karolinska Institutet. He continues to collaborate with many investigators in studies of cholesterol and lipoprotein metabolism in human patients and he also studies the role of cholesterol esterification in mouse models of atherosclerosis. Definition of pathways of cholesterol metabolism in atherosclerosis and gallstone disease are avenues of research that Dr. Parini has studied throughout 25 years of scientific investigation. His work traditionally includes basic and translational components. His ability to adapt his research activities to include many rapidly developing new research technologies has consistently been a noticeable strength of his program.